INTERREG 2 Seas – IMODE – Innovative MulticOmponent Drug dEsign (Advanced materials and pharmaceutical technologies)
Goals:
- Reinforce R&D by designing innovative drugs and medical devices, ready to use and patentable, based on new multi-component materials with enhanced therapeutic properties
- Ensure the knowledge transfer to provide a high-qualified labor force (scientists and technicians from both academic and industrial community, students)
Activities carried out by Eurasanté:
- Technological transfer
- Communication activities, building a network and organizing events
- Provide a support in medical, marketing, training and networking fields
Duration: 60 months
Official start: 01.07.2016
Budget: € 5 910 275
Head of project: University of Lille – Sciences and Technologies – FR
Partners:
- Eurasanté (FR), University of Lille – Faculty of medicine (FR), ImaBiotech (FR), Roquette Frères (FR), University College of London (UK), University of East Anglia (UK), University of Greenwich (UK), Ashford and St. Peter’s Hospitals NHS Foundation Trust (UK), Cubic Pharmaceutical Ltd (UK), University of Ghent (BE)
